Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma.

Autor: Tang SW; Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1 Jen-Ai Road First Section, Taipei 100, Taiwan., Lin JY

Publikováno v: Journal of oncology [J Oncol] 2012; Vol. 2012, pp. 680796. Date of Electronic Publication: 2012 Mar 20.

Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma

Autor: Sai-Wen Tang, Jung-Yaw Lin

Publikováno v: Journal of Oncology
Journal of Oncology, Vol 2012 (2012)

Clear cell renal cell carcinoma (ccRCC), the most common subtype of RCC, is characterized by high metastasis potential and strong resistance to traditional therapies, resulting in a poor five-year survival rate of patients. Several therapies targeted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691a8ba6e4292b8db829347e530d1032
https://pubmed.ncbi.nlm.nih.gov/22545051

Ca ²⁺ and Annexins - Emerging Players for Sensing and Transferring Cholesterol and Phosphoinositides via Membrane Contact Sites.

Autor: Enrich C; Departament de Biomedicina, Unitat de Biologia Cel⋅lular, Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. enrich@ub.edu.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. enrich@ub.edu., Lu A; Departament de Biomedicina, Unitat de Biologia Cel⋅lular, Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Tebar F; Departament de Biomedicina, Unitat de Biologia Cel⋅lular, Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Rentero C; Departament de Biomedicina, Unitat de Biologia Cel⋅lular, Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Grewal T; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Publikováno v: Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1422, pp. 393-438.

Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation.

Autor: Martinez-Campanario MC; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, IDIBAPS, 08036, Barcelona, Spain., Cortés M; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, IDIBAPS, 08036, Barcelona, Spain., Moreno-Lanceta A; Department of Biomedicine, University of Barcelona School of Medicine, 08036, Barcelona, Spain., Han L; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, IDIBAPS, 08036, Barcelona, Spain., Ninfali C; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, IDIBAPS, 08036, Barcelona, Spain., Domínguez V; Transgenesis Facility, National Center of Biotechnology (CNB) and Center for Molecular Biology Severo Ochoa (UAM-CBMSO), Spanish National Research Council (CSIC) and Autonomous University of Madrid (UAM), Cantoblanco, 28049, Madrid, Spain., Andrés-Manzano MJ; Group of Molecular and Genetic Cardiovascular Pathophysiology, Spanish National Center for Cardiovascular Research (CNIC), 28029, Madrid, Spain.; Center for Biomedical, Research Network in Cardiovascular Diseases (CIBERCV), Carlos III Health Institute, 28029, Madrid, Spain., Farràs M; Department of Biochemistry and Molecular Biology, Institute of Biomedical Research Sant Pau, University Autonomous of Barcelona, 08041, Barcelona, Spain.; Center for Biomedical Research Network in Diabetes and Associated Metabolic Diseases (CIBERDEM), Carlos III Health Institute, 28029, Madrid, Spain., Esteve-Codina A; National Center for Genomics Analysis (CNAG), 08028, Barcelona, Spain., Enrich C; Department of Biomedicine, University of Barcelona School of Medicine, 08036, Barcelona, Spain.; Group of signal transduction, intracellular compartments and cancer, IDIBAPS, 08036, Barcelona, Spain., Díaz-Crespo FJ; Department of Pathology, Hospital General Universitario Gregorio Marañón, 28007, Madrid, Spain., Pintado B; Transgenesis Facility, National Center of Biotechnology (CNB) and Center for Molecular Biology Severo Ochoa (UAM-CBMSO), Spanish National Research Council (CSIC) and Autonomous University of Madrid (UAM), Cantoblanco, 28049, Madrid, Spain., Escolà-Gil JC; Department of Biochemistry and Molecular Biology, Institute of Biomedical Research Sant Pau, University Autonomous of Barcelona, 08041, Barcelona, Spain.; Center for Biomedical Research Network in Diabetes and Associated Metabolic Diseases (CIBERDEM), Carlos III Health Institute, 28029, Madrid, Spain., García de Frutos P; Center for Biomedical, Research Network in Cardiovascular Diseases (CIBERCV), Carlos III Health Institute, 28029, Madrid, Spain.; Department Of Cell Death and Proliferation, Institute for Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), 08036, Barcelona, Spain.; Group of Hemotherapy and Hemostasis, IDIBAPS, 08036, Barcelona, Spain., Andrés V; Group of Molecular and Genetic Cardiovascular Pathophysiology, Spanish National Center for Cardiovascular Research (CNIC), 28029, Madrid, Spain.; Center for Biomedical, Research Network in Cardiovascular Diseases (CIBERCV), Carlos III Health Institute, 28029, Madrid, Spain., Melgar-Lesmes P; Department of Biomedicine, University of Barcelona School of Medicine, 08036, Barcelona, Spain.; Department of Biochemistry and Molecular Genetics, Hospital Clínic, 08036, Barcelona, Spain.; Center for Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III Health Institute, 28029, Madrid, Spain.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology (MIT), Cambridge, MA, 02139, USA., Postigo A; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, IDIBAPS, 08036, Barcelona, Spain. idib412@recerca.clinic.cat.; Center for Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III Health Institute, 28029, Madrid, Spain. idib412@recerca.clinic.cat.; Molecular Targets Program, Division of Oncology, Department of Medicine, J.G. Brown Cancer Center, Louisville, KY, 40202, USA. idib412@recerca.clinic.cat.; ICREA, 08010, Barcelona, Spain. idib412@recerca.clinic.cat.

Publikováno v: Nature communications [Nat Commun] 2023 Dec 14; Vol. 14 (1), pp. 8316. Date of Electronic Publication: 2023 Dec 14.

The adaptive antioxidant response during fasting-induced muscle atrophy is oppositely regulated by ZEB1 and ZEB2.

Autor: Ninfali C; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain., Cortés M; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain., Martínez-Campanario MC; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain., Domínguez V; National Center of Biotechnology (CSIC-CNB) and Center for Molecular Biology Severo Ochoa (CSIC-CBMSO), Transgenesis Facility, High Research Council (CSIC) and Autonomous University of Madrid, Cantoblanco, Madrid 28049, Spain., Han L; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain., Tobías E; Group of Muscle Research and Mitochondrial Function, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), University of Barcelona School of Medicine, Hospital Clínic of Barcelona, and Rare Diseases Networking Biomedical Research Center (CIBERer), Barcelona 08036, Spain., Esteve-Codina A; National Center for Genomics Analysis (CNAG), Barcelona 08028, Spain., Enrich C; Department of Biomedicine, University of Barcelona School of Medicine, and Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain., Pintado B; National Center of Biotechnology (CSIC-CNB) and Center for Molecular Biology Severo Ochoa (CSIC-CBMSO), Transgenesis Facility, High Research Council (CSIC) and Autonomous University of Madrid, Cantoblanco, Madrid 28049, Spain., Garrabou G; Group of Muscle Research and Mitochondrial Function, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), University of Barcelona School of Medicine, Hospital Clínic of Barcelona, and Rare Diseases Networking Biomedical Research Center (CIBERer), Barcelona 08036, Spain., Postigo A; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona 08036, Spain.; Molecular Targets Program, Department of Medicine, James Graham Brown Cancer Center, Louisville, KY 40202.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona 08010, Spain.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Nov 14; Vol. 120 (46), pp. e2301120120. Date of Electronic Publication: 2023 Nov 10.